Sexually Transmitted Disease

Genital Herpes a Substantial Financial Burden on U.S.

Published in Medical Letter on the CDC and FDA, March 6th, 2000

Physician visits and drugs used in the treatment of genital herpes costs the United States over $200 million annually, according to a study published in Sexually Transmitted Diseases.

"Approximately 45 million Americans have serologic evidence of HSV-2 infection and HSV-2 seroprevalence has increased 30% over the past two decades," according to G.Y. Tao and colleagues at the U.S. Centers for Disease Control and Prevention ("Medical care expenditures for genital herpes in the United States," Sexually Transmitted Diseases, January 2000;27(1):32-38). Despite the rapid increase in herpes cases, Tao et al. noted that the last cost estimate for genital herpes...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2000-03-06)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry